Kimberly Wilber serves as the Director of Research and Development at Abbott Molecular, where she spearheads the development of cutting-edge in vitro diagnostic medical devices. With a robust background in medical device product development and project management, Kimberly leads cross-functional teams focused on creating innovative...
Kimberly Wilber serves as the Director of Research and Development at Abbott Molecular, where she spearheads the development of cutting-edge in vitro diagnostic medical devices. With a robust background in medical device product development and project management, Kimberly leads cross-functional teams focused on creating innovative solutions that enhance cancer prognosis and diagnosis. Her expertise in design control and design transfer ensures that products not only meet stringent regulatory requirements, including those set forth by the U.S. Food and Drug Administration (FDA) and CE marking, but also align with the principles of Good Laboratory Practice (GLP).
At Abbott Molecular, Kimberly is currently overseeing several key projects that integrate personalized medicine with advanced molecular diagnostics. Her leadership is instrumental in the development of companion diagnostics that provide critical insights into patient-specific treatment pathways, thereby improving clinical outcomes. By fostering a culture of innovation and collaboration, she empowers her teams to push the boundaries of technology and science, ensuring that Abbott remains at the forefront of the rapidly evolving diagnostics landscape.
Kimberly’s proficiency in molecular biology and her commitment to advancing healthcare through innovative diagnostics underscore her role as a thought leader in the industry. Her ability to navigate complex regulatory environments while maintaining a focus on quality and efficacy positions her as a pivotal figure in the development of next-generation diagnostic tools. As she continues to drive strategic initiatives at Abbott Molecular, Kimberly Wilber exemplifies the intersection of science, technology, and patient care, making significant contributions to the field of molecular diagnostics.
